HCA Healthcare, Inc. $HCA Shares Sold by Natixis Advisors LLC

Natixis Advisors LLC cut its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.8% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 124,507 shares of the company’s stock after selling 4,889 shares during the quarter. Natixis Advisors LLC owned 0.05% of HCA Healthcare worth $53,065,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its stake in shares of HCA Healthcare by 8.0% in the 3rd quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 2,700 shares of the company’s stock worth $1,151,000 after purchasing an additional 200 shares during the last quarter. Munich Reinsurance Co Stock Corp in Munich acquired a new position in HCA Healthcare in the third quarter worth approximately $2,374,000. Angeles Wealth Management LLC lifted its position in shares of HCA Healthcare by 2.4% during the 3rd quarter. Angeles Wealth Management LLC now owns 1,014 shares of the company’s stock valued at $432,000 after acquiring an additional 24 shares during the last quarter. Evexia Wealth LLC grew its holdings in shares of HCA Healthcare by 16.7% in the 3rd quarter. Evexia Wealth LLC now owns 18,046 shares of the company’s stock worth $7,411,000 after acquiring an additional 2,589 shares during the last quarter. Finally, First Trust Advisors LP lifted its holdings in shares of HCA Healthcare by 46.5% during the third quarter. First Trust Advisors LP now owns 127,552 shares of the company’s stock valued at $54,363,000 after purchasing an additional 40,476 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 2.5%

HCA Healthcare stock opened at $545.88 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $310.18 and a 12 month high of $552.90. The company’s fifty day simple moving average is $501.78 and its 200-day simple moving average is $466.79. The stock has a market cap of $122.07 billion, a P/E ratio of 19.23, a P/E/G ratio of 1.64 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the firm earned $6.22 earnings per share. The business’s revenue for the quarter was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is 10.15%.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the sale, the executive vice president owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 15,214 shares of company stock worth $7,797,595. Company insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on HCA. JPMorgan Chase & Co. boosted their price objective on HCA Healthcare from $420.00 to $535.00 and gave the stock a “neutral” rating in a report on Friday, February 20th. Jefferies Financial Group upped their price target on shares of HCA Healthcare from $535.00 to $590.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Oppenheimer lifted their price objective on shares of HCA Healthcare from $500.00 to $540.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 target price on HCA Healthcare in a research report on Monday, February 9th. Finally, Leerink Partners increased their price objective on HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $534.50.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.